Statement Of Cash Flows [Abstract]

Innate Pharma - Filing #5981200

Concept 2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
As at
2024-12-31
2024-01-01 to
2024-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
As at
2022-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Profit (loss)
49 471 EUR
EUR
EUR
EUR
EUR
EUR
49 471 EUR
EUR
7 570 EUR
7 570 EUR
EUR
EUR
EUR
EUR
EUR
EUR
Adjustments to reconcile profit (loss) [abstract]
Adjustments for unrealised foreign exchange losses (gains)
885,000 EUR
544,000 EUR
Adjustments for share-based payments
3 944 EUR
4 256 EUR
Adjustments for fair value losses (gains)
1 335 EUR
1 592 EUR
Adjustments for losses (gains) on disposal of non-current assets
20,000 EUR
470,000 EUR
Other adjustments to reconcile profit (loss)
24,000 EUR
6,000 EUR
Interest paid, classified as operating activities
13,000,000 EUR
6,000,000 EUR
Interest received, classified as operating activities
19,000,000 EUR
22,000,000 EUR
Cash flows from (used in) operating activities
6 896 EUR
32 559 EUR
Cash flows from (used in) investing activities [abstract]
Proceeds from sales of property, plant and equipment, classified as investing activities
EUR
150,000 EUR
Purchase of property, plant and equipment, classified as investing activities
391,000 EUR
351,000 EUR
Purchase of intangible assets, classified as investing activities
EUR
2 000 EUR
Proceeds from sales of other long-term assets, classified as investing activities
EUR
66,000 EUR
Purchase of other long-term assets, classified as investing activities
EUR
3,000 EUR
Cash flows from (used in) investing activities
9 200 EUR
20 630 EUR
Cash flows from (used in) financing activities [abstract]
Cash flows from (used in) financing activities
6 008 EUR
1 966 EUR
Effect of exchange rate changes on cash and cash equivalents [abstract]
Effect of exchange rate changes on cash and cash equivalents
505,000 EUR
274,000 EUR
Increase (decrease) in cash and cash equivalents after effect of exchange rate changes
4 209 EUR
13 619 EUR
Cash and cash equivalents
66 396 EUR
70 605 EUR
84 225 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.